nodes	percent_of_prediction	percent_of_DWPC	metapath
Linagliptin—CYP3A4—Esomeprazole—Barrett's esophagus	0.286	0.389	CbGbCtD
Linagliptin—ABCB1—Omeprazole—Barrett's esophagus	0.281	0.382	CbGbCtD
Linagliptin—CYP3A4—Omeprazole—Barrett's esophagus	0.168	0.229	CbGbCtD
Linagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—CDX2—Barrett's esophagus	0.0212	0.319	CbGpPWpGaD
Linagliptin—DPP4—Incretin synthesis, secretion, and inactivation—CDX2—Barrett's esophagus	0.0188	0.284	CbGpPWpGaD
Linagliptin—DPP4—exocrine gland—Barrett's esophagus	0.014	0.405	CbGeAlD
Linagliptin—DPP4—Peptide hormone metabolism—CDX2—Barrett's esophagus	0.00638	0.0962	CbGpPWpGaD
Linagliptin—DPP4—epithelium—Barrett's esophagus	0.00607	0.176	CbGeAlD
Linagliptin—DPP4—smooth muscle tissue—Barrett's esophagus	0.00585	0.17	CbGeAlD
Linagliptin—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.00507	0.0309	CcSEcCtD
Linagliptin—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.00507	0.0309	CcSEcCtD
Linagliptin—Pain in extremity—Omeprazole—Barrett's esophagus	0.00495	0.0302	CcSEcCtD
Linagliptin—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00495	0.0302	CcSEcCtD
Linagliptin—DPP4—digestive system—Barrett's esophagus	0.00462	0.134	CbGeAlD
Linagliptin—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00419	0.0256	CcSEcCtD
Linagliptin—Pancreatitis—Omeprazole—Barrett's esophagus	0.00419	0.0256	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00397	0.0243	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00397	0.0243	CcSEcCtD
Linagliptin—Weight increased—Esomeprazole—Barrett's esophagus	0.00389	0.0237	CcSEcCtD
Linagliptin—Weight increased—Omeprazole—Barrett's esophagus	0.00389	0.0237	CcSEcCtD
Linagliptin—Infestation—Omeprazole—Barrett's esophagus	0.00381	0.0233	CcSEcCtD
Linagliptin—Infestation NOS—Omeprazole—Barrett's esophagus	0.00381	0.0233	CcSEcCtD
Linagliptin—Infestation—Esomeprazole—Barrett's esophagus	0.00381	0.0233	CcSEcCtD
Linagliptin—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00381	0.0233	CcSEcCtD
Linagliptin—Urinary tract infection—Omeprazole—Barrett's esophagus	0.0037	0.0226	CcSEcCtD
Linagliptin—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.0037	0.0226	CcSEcCtD
Linagliptin—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00327	0.0493	CbGpPWpGaD
Linagliptin—Immune system disorder—Esomeprazole—Barrett's esophagus	0.00309	0.0189	CcSEcCtD
Linagliptin—Immune system disorder—Omeprazole—Barrett's esophagus	0.00309	0.0189	CcSEcCtD
Linagliptin—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00308	0.0188	CcSEcCtD
Linagliptin—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00308	0.0188	CcSEcCtD
Linagliptin—Malnutrition—Omeprazole—Barrett's esophagus	0.00298	0.0182	CcSEcCtD
Linagliptin—Malnutrition—Esomeprazole—Barrett's esophagus	0.00298	0.0182	CcSEcCtD
Linagliptin—Back pain—Esomeprazole—Barrett's esophagus	0.00288	0.0176	CcSEcCtD
Linagliptin—Back pain—Omeprazole—Barrett's esophagus	0.00288	0.0176	CcSEcCtD
Linagliptin—Angioedema—Esomeprazole—Barrett's esophagus	0.00272	0.0166	CcSEcCtD
Linagliptin—Angioedema—Omeprazole—Barrett's esophagus	0.00272	0.0166	CcSEcCtD
Linagliptin—Cough—Esomeprazole—Barrett's esophagus	0.0026	0.0159	CcSEcCtD
Linagliptin—Cough—Omeprazole—Barrett's esophagus	0.0026	0.0159	CcSEcCtD
Linagliptin—Arthralgia—Omeprazole—Barrett's esophagus	0.00254	0.0155	CcSEcCtD
Linagliptin—Arthralgia—Esomeprazole—Barrett's esophagus	0.00254	0.0155	CcSEcCtD
Linagliptin—Myalgia—Omeprazole—Barrett's esophagus	0.00254	0.0155	CcSEcCtD
Linagliptin—Myalgia—Esomeprazole—Barrett's esophagus	0.00254	0.0155	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00252	0.0154	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00252	0.0154	CcSEcCtD
Linagliptin—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00243	0.0148	CcSEcCtD
Linagliptin—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00243	0.0148	CcSEcCtD
Linagliptin—Infection—Omeprazole—Barrett's esophagus	0.00241	0.0147	CcSEcCtD
Linagliptin—Infection—Esomeprazole—Barrett's esophagus	0.00241	0.0147	CcSEcCtD
Linagliptin—Skin disorder—Omeprazole—Barrett's esophagus	0.00236	0.0144	CcSEcCtD
Linagliptin—Skin disorder—Esomeprazole—Barrett's esophagus	0.00236	0.0144	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00221	0.0135	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00221	0.0135	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.0021	0.0128	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.0021	0.0128	CcSEcCtD
Linagliptin—Constipation—Omeprazole—Barrett's esophagus	0.00208	0.0127	CcSEcCtD
Linagliptin—Constipation—Esomeprazole—Barrett's esophagus	0.00208	0.0127	CcSEcCtD
Linagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00202	0.0304	CbGpPWpGaD
Linagliptin—Urticaria—Esomeprazole—Barrett's esophagus	0.00193	0.0118	CcSEcCtD
Linagliptin—Urticaria—Omeprazole—Barrett's esophagus	0.00193	0.0118	CcSEcCtD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00188	0.0283	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00188	0.0283	CbGpPWpGaD
Linagliptin—Hypersensitivity—Omeprazole—Barrett's esophagus	0.00179	0.0109	CcSEcCtD
Linagliptin—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.00179	0.0109	CcSEcCtD
Linagliptin—Diarrhoea—Omeprazole—Barrett's esophagus	0.00166	0.0102	CcSEcCtD
Linagliptin—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00166	0.0102	CcSEcCtD
Linagliptin—Rash—Omeprazole—Barrett's esophagus	0.00153	0.00936	CcSEcCtD
Linagliptin—Rash—Esomeprazole—Barrett's esophagus	0.00153	0.00936	CcSEcCtD
Linagliptin—Dermatitis—Esomeprazole—Barrett's esophagus	0.00153	0.00935	CcSEcCtD
Linagliptin—Dermatitis—Omeprazole—Barrett's esophagus	0.00153	0.00935	CcSEcCtD
Linagliptin—Headache—Omeprazole—Barrett's esophagus	0.00152	0.0093	CcSEcCtD
Linagliptin—Headache—Esomeprazole—Barrett's esophagus	0.00152	0.0093	CcSEcCtD
Linagliptin—CYP3A4—digestive system—Barrett's esophagus	0.00151	0.0437	CbGeAlD
Linagliptin—ABCB1—epithelium—Barrett's esophagus	0.0014	0.0407	CbGeAlD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.00121	0.0182	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—CDX2—Barrett's esophagus	0.0012	0.0182	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00116	0.0175	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00116	0.0175	CbGpPWpGaD
Linagliptin—ABCB1—digestive system—Barrett's esophagus	0.00107	0.0309	CbGeAlD
Linagliptin—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000803	0.0121	CbGpPWpGaD
Linagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000735	0.0111	CbGpPWpGaD
Linagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000726	0.0109	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000619	0.00932	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000596	0.00899	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000381	0.00575	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000317	0.00477	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000312	0.00471	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—CXCL8—Barrett's esophagus	0.000257	0.00388	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	0.00024	0.00362	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000221	0.00333	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000161	0.00243	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000135	0.00204	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000122	0.00184	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PTGES—Barrett's esophagus	0.000116	0.00175	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	8.79e-05	0.00132	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	7.28e-05	0.0011	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PTGES—Barrett's esophagus	7.15e-05	0.00108	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	6.34e-05	0.000955	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	5.42e-05	0.000816	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	3.9e-05	0.000588	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPARG—Barrett's esophagus	2.89e-05	0.000436	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PTGS2—Barrett's esophagus	2.28e-05	0.000343	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPARG—Barrett's esophagus	1.78e-05	0.000269	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	1.4e-05	0.000211	CbGpPWpGaD
